IFN-γ

Home
Ligands
IFN-γ (Human)

GtoPdb Ligand ID: 4968

Synonyms: Actimmune® | immune interferon | interferon gamma

IFN-γ is an approved drug (FDA (1999))

Compound class: Endogenous peptide in human, mouse or rat

Comment: IFN-γ is a type II interferon. It is biologically active as a homodimer.

Species: Human

View more information in the IUPHAR Pharmacology Education Project: interferon-gamma (ifn-γ)

Summary
Biological activity
Clinical data
References
Structure
Similar ligands
Immunopharmacology

References
1. Ferlin W, Fischer N, Elson G, Leger O. (2006) Human anti-interferon gamma antibodies and methods of use thereof. Patent number: WO2006109191. Assignee: Novimmune S.A.. Priority date: 27/01/2005. Publication date: 19/10/2006.
2. Vasquez M, Landolfi NF, Tsurushita N, Queen CL. (2001) Humanized antibodies to γ-interferon. Patent number: US6329511B1. Assignee: Protein Design Labs Inc. Priority date: 01/12/1998. Publication date: 11/12/2001.

References

1. Ferlin W, Fischer N, Elson G, Leger O. (2006)
Human anti-interferon gamma antibodies and methods of use thereof.
Patent number: WO2006109191. Assignee: Novimmune S.A.. Priority date: 27/01/2005. Publication date: 19/10/2006.

2. Vasquez M, Landolfi NF, Tsurushita N, Queen CL. (2001)
Humanized antibodies to γ-interferon.
Patent number: US6329511B1. Assignee: Protein Design Labs Inc. Priority date: 01/12/1998. Publication date: 11/12/2001.